Literature DB >> 3357090

Transient synovitis of the hip in the child: increased levels of proteoglycan fragments in joint fluid.

L S Lohmander1, H Wingstrand, D Heinegård.   

Abstract

The levels of proteoglycan antigen were measured in joint aspirates from the hip of children with transient synovitis, septic arthritis, Legg-Calvé-Perthes' disease and congenital and traumatic dislocation. Significantly increased levels were found in children with transient synovitis and septic arthritis as compared with other conditions. We propose that the proteoglycan antigens in the joint fluid were released from the articular cartilage in a partially degraded form as a result of an increased rate of proteolytic degradation. In transient synovitis, the source of proteolytic activity may be chondrocytes activated by factors released by synovial cells. The release of joint proteoglycan may cause a temporary increase in deformability of the hip cartilage of the child that could be an important pathogenetic mechanism in some of the sequelae of these diseases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3357090     DOI: 10.1002/jor.1100060313

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  3 in total

1.  Increased concentrations of proteoglycan components in the synovial fluids of patients with acute but not chronic joint disease.

Authors:  A Ratcliffe; M Doherty; R N Maini; T E Hardingham
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

2.  Comparison of keratan sulphate concentrations and the size distribution of proteoglycans in the synovial fluid of patients with osteoarthritis and pyrophosphate arthropathy.

Authors:  G Carroll; S McCappin; M Bell; A Schwarzer; P Breidahl
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

3.  New insights into the biomechanics of Legg-Calvé-Perthes' disease: The Role of Epiphyseal Skeletal Immaturity in Vascular Obstruction.

Authors:  M Pinheiro; C A Dobson; D Perry; M J Fagan
Journal:  Bone Joint Res       Date:  2018-02       Impact factor: 5.853

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.